ReviewThe oncologist2025

Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review.

Tingting Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.